SUBSCRIBE
SUBSCRIBE

Alliances

Japan's Konica Minolta Takes Out SoCal Diagnostics Firm Ambry Genetics in $1 Billion Deal
Business
Turns Out Editas Medicine’s R&D Deal With Allergan Could be Worth $1 Billion
March 23, 2017
 · 
3 min read
Business
Johnson & Johnson, GlaxoSmithKline Yank Ads From YouTube
March 23, 2017
 · 
1 min read
Biotech Giant Amgen Bets $1.5 Billion on Bay Area CytomX's Cancer Drugs
Business
Bay Area’s CytomX Surges as Bristol-Myers Squibb Signs Up for 8 More Projects With $200 Million Upfront in Deal Totaling $5 Billion
March 20, 2017
 · 
2 min read
Business
A Drug Company Just Struck A Deal To Discount The Price Of A Lifesaving Diabetes Medication To $25
March 17, 2017
 · 
1 min read
Ablynx Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi
Business
Bernie Sanders: Trump Must Stop Sanofi’s Exclusive Zika Deal
March 14, 2017
 · 
3 min read
Tiny KalVista Explodes on $760 Million Deal With Drug Giant Merck & Co.
Business
Sanofi Pasteur Inks $645 Million RSV Deal With AstraZeneca PLC’s MedImmune
March 3, 2017
 · 
3 min read
A Look Inside Takeda's Remarkable R&D Transformation
Business
A Look Inside Takeda’s Remarkable R&D Transformation
February 27, 2017
 · 
2 min read
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Business
Why This 11-Employee Massachusetts Biotech’s Market Cap Doubled Yesterday
February 22, 2017
 · 
2 min read
5 Biotechs Awaiting Big News From the FDA in July
Business
Questions Arise Over a Congressman’s Ties With Australian Biotech Innate Immunotherapeutics
February 20, 2017
 · 
3 min read
SAGE Therapeutics Crashes Hard as Lead Epilepsy Drug Flunks Phase III Test
Business
SAGE Therapeutics Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity
February 17, 2017
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma
August 28, 2025
 · 
3 min read
Press Releases
Pendopharm® signs an exclusive distribution agreement with Neuraxpharm for PrBuccolam® in Canada and announces its approval by Health Canada
August 4, 2025
 · 
4 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.
July 31, 2025
 · 
3 min read
Press Releases
Accelerating Impact: AstraZeneca and Revna Biosciences Expand Access to Lung Cancer Treatment in Ghana
July 30, 2025
 · 
4 min read
Press Releases
JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines
July 8, 2025
 · 
5 min read
Press Releases
Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it’s Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®
June 30, 2025
 · 
8 min read
Press Releases
Mabwell Announces Novel Drug Technology License Agreement with Qilu Pharmaceutical for Albipagrastim alfa for Injection
June 27, 2025
 · 
5 min read
Press Releases
Miraomics, Pythia Biosciences and LatchBio Release a 30 Million Cell Atlas and an Agentric AI Framework for Molecular Data Curation
June 27, 2025
 · 
2 min read
Press Releases
Cyberlux Corporation Signs Strategic MoU with George Mason University to Accelerate Defense Innovation and Technology Commercialization
June 27, 2025
 · 
3 min read
Press Releases
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
June 26, 2025
 · 
5 min read
Press Releases
Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’s Certepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer
June 26, 2025
 · 
10 min read
Press Releases
CMUH and Shine-On Biomedical Lead Taiwan’s Push into Global Exosome-Based Precision Medicine
June 26, 2025
 · 
3 min read
Press Releases
KalVista Pharmaceuticals Enters into Licensing Agreement with Pendopharm to Commercialize Sebetralstat for HAE in Canada
June 26, 2025
 · 
4 min read
Press Releases
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
June 25, 2025
 · 
7 min read
Press Releases
Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.
June 25, 2025
 · 
5 min read
Press Releases
Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences
June 25, 2025
 · 
5 min read
Press Releases
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
June 25, 2025
 · 
5 min read
Press Releases
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
June 25, 2025
 · 
6 min read
Press Releases
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
June 25, 2025
 · 
5 min read
Press Releases
ONCare Alliance and Exigent Research Launch Groundbreaking Outpatient Bispecifics Program, Redefining Cancer Care Access, Support and Innovation
June 25, 2025
 · 
3 min read
Load More